Immix Biopharma, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -2.79 | -100% |
| P/S |
|
-0.3103 | 33.77 | -100.92% |
|
|
| P/BV |
|
7.46 | 4.83 | 54.5% |
|
|
| P/FCF |
|
-2.92 | 61 | -104.78% |
|
|
| Ev/Ebitda |
|
-6.41 | -22.17 | -71.1% |
|
|
| Ev/S |
|
-1.15 | 22.57 | -105.12% |
|
|
| Ev/FCF |
|
-9.05 | 68.76 | -113.16% |
|
|
| E/P |
|
-0.4632 | 0.0178 | -2706.1% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | 9.18 | -100% |
| ROE |
|
-94.03 | 9.61 | -1078.32% |
|
|
| ROA |
|
-77.42 | 0.3443 | -22588.84% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
17.24 | -25.17 | -168.49% |
|
|
| ROCE |
|
-99.61 | 15.45 | -744.74% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0 | -3.68 | -100% | -1.83 | -100% |
| Nеt Debt/Ebitda |
|
1.09 | -3.44 | -131.57% |
|
|
| Debt/Ratio |
|
0 | 0.1986 | -100% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
0 | 10.32 | -100% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -57.64 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
1818.19 | -90.94 | -2099.33% | ||
| Growth impulse Net Income in 5 years |
|
1485.72 | -97.8 | -1619.14% | ||
| Growth impulse FCF in 5 years |
|
1332.7 | -108.72 | -1325.81% | ||
| Growth impulse EPS in 5 years |
|
672.01 | -142.05 | -573.08% |
IP Score
4.19/10
